Literature DB >> 22882195

Toward defining grade C pancreatic fistula following pancreaticoduodenectomy: incidence, risk factors, management and outcome.

Jason W Denbo1, W Shannon Orr, Ben L Zarzaur, Stephen W Behrman.   

Abstract

BACKGROUND: In 2005 the International Study Group for Pancreatic Fistula (ISGPF) created a definition and grading system for pancreatic fistulae (PF) in which grade C denotes the most severe and potentially life-threatening type. Factors and outcomes associated with grade C fistulae have been ill defined.
METHODS: Systematic searches of PubMed and EMBASE were conducted by two independent reviewers utilizing the keywords 'pancreaticoduodenectomy' (PD) and 'pancreatic fistula'. Inclusion criteria were: (i) a sample of ≥100 patients; (ii) consecutive accrual of all pathologies, and (iii) use of the ISGPF definition and grading system. Quality appraisal and data extraction were performed using pilot-tested templates.
RESULTS: Fourteen articles describing a total of 2706 PDs met the study entrance criteria. Pancreatic fistulae occurred in 479 patients (18%) and included 71 grade C PF that were directly responsible for 25 deaths (35% mortality rate). Only two studies analysed risk factors; these found soft pancreatic texture and histology other than adenocarcinoma to be the most common risk factors. Ten studies reported management strategies and indicated that 51% of patients required reoperation.
CONCLUSIONS: Grade C PF: (i) accounts for 15% of fistulae following PD and has an associated mortality rate of 35%; (ii) occurs most commonly in pathology associated with a soft remnant, and (iii) requires reoperation in approximately one half of patients. The published literature incompletely describes grade C PF.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 22882195      PMCID: PMC3461384          DOI: 10.1111/j.1477-2574.2012.00486.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  35 in total

1.  Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant.

Authors:  M I van Berge Henegouwen; L T De Wit; T M Van Gulik; H Obertop; D J Gouma
Journal:  J Am Coll Surg       Date:  1997-07       Impact factor: 6.113

2.  Risk factors for postoperative pancreatic fistula after pancreaticoduodenectomy: the significance of the ratio of the main pancreatic duct to the pancreas body as a predictor of leakage.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Masahiko Komagome; Nobuhiro Shin; Narihiro Cho; Takashi Ishida; Fumiaki Ozawa; Daijo Hashimoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2010-01-26       Impact factor: 7.027

3.  Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection.

Authors:  L Rosenberg; P MacNeil; L Turcotte
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

4.  Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy.

Authors:  Michelle L DeOliveira; Jordan M Winter; Markus Schafer; Steven C Cunningham; John L Cameron; Charles J Yeo; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

5.  How do we predict the clinically relevant pancreatic fistula after pancreaticoduodenectomy?--an analysis in 244 consecutive patients.

Authors:  Manabu Kawai; Masaji Tani; Seiko Hirono; Shinomi Ina; Motoki Miyazawa; Hiroki Yamaue
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

6.  A modern analysis of morbidity after pancreatic resection.

Authors:  Stephen W Behrman; Benjamin T Rush; Raza A Dilawari
Journal:  Am Surg       Date:  2004-08       Impact factor: 0.688

7.  Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group.

Authors:  J P Neoptolemos; R C Russell; S Bramhall; B Theis
Journal:  Br J Surg       Date:  1997-10       Impact factor: 6.939

8.  Results of pancreaticogastrostomy after pancreaticoduodenectomy in 159 consecutive cases.

Authors:  Zbigniew Sledziński; Justyna Z Kostro; Dariusz Zadrozny; Ignacy Pirski; Marian Lukiański; Janusz Głowacki
Journal:  Pancreatology       Date:  2008-01-31       Impact factor: 3.996

9.  The complications of pancreatectomy.

Authors:  M Trede; G Schwall
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

10.  Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management.

Authors:  J J Cullen; M G Sarr; D M Ilstrup
Journal:  Am J Surg       Date:  1994-10       Impact factor: 2.565

View more
  21 in total

1.  Surgery indeed has an important role in long-term outcome in patients with pancreatic head cancer.

Authors:  Darko Zdravkovic; Dragoljub Bilanovic; Tomislav Randjelovic; Marija Zdravkovic; Srdjan Dikic
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

Review 2.  Total robotic pancreaticoduodenectomy: a systematic review of the literature.

Authors:  Michail Kornaropoulos; Demetrios Moris; Eliza W Beal; Marinos C Makris; Apostolos Mitrousias; Athanasios Petrou; Evangelos Felekouras; Adamantios Michalinos; Michail Vailas; Dimitrios Schizas; Alexandros Papalampros
Journal:  Surg Endosc       Date:  2017-04-07       Impact factor: 4.584

3.  Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality.

Authors:  Jason W Denbo; Morgan L Bruno; Jordan M Cloyd; Laura Prakash; Jeffrey E Lee; Michael Kim; Christopher H Crane; Eugene J Koay; Sunil Krishnan; Prajnan Das; Bruce D Minsky; Gauri Varadhachary; Rachna Shroff; Robert Wolff; Milind Javle; Michael J Overman; David Fogelman; Thomas A Aloia; Jean-Nicolas Vauthey; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2016-10-11       Impact factor: 3.452

Review 4.  Defining post-operative pancreatitis as a new pancreatic specific complication following pancreatic resection.

Authors:  Saxon Connor
Journal:  HPB (Oxford)       Date:  2016-06-20       Impact factor: 3.647

5.  250 robotic pancreatic resections: safety and feasibility.

Authors:  Amer H Zureikat; A James Moser; Brian A Boone; David L Bartlett; Mazen Zenati; Herbert J Zeh
Journal:  Ann Surg       Date:  2013-10       Impact factor: 12.969

6.  Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy.

Authors:  Jason W Denbo; Morgan Bruno; Whitney Dewhurst; Michael P Kim; Ching-Wei Tzeng; Thomas A Aloia; Jose Soliz; Barbara Bryce Speer; Jeffrey E Lee; Matthew H G Katz
Journal:  Surgery       Date:  2018-05-25       Impact factor: 3.982

Review 7.  Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.

Authors:  Thilo Welsch; Benjamin Müssle; Marius Distler; Holger Knoth; Jürgen Weitz; Dennis Häckl
Journal:  Langenbecks Arch Surg       Date:  2016-05-28       Impact factor: 3.445

8.  An analysis of risk factors for pancreatic fistula after robotic pancreaticoduodenectomy: outcomes from a consecutive series of standardized pancreatic reconstructions.

Authors:  Patricio M Polanco; Mazen S Zenati; Melissa E Hogg; Murtaza Shakir; Brian A Boone; David L Bartlett; Herbert J Zeh; Amer H Zureikat
Journal:  Surg Endosc       Date:  2015-07-03       Impact factor: 4.584

9.  Neoadjuvant Radiation Is Associated with Fistula Formation Following Pancreaticoduodenectomy.

Authors:  Sara L Zettervall; Tammy Ju; Jeremy L Holzmacher; Lisbi Rivas; Paul P Lin; Khashayar Vaziri
Journal:  J Gastrointest Surg       Date:  2018-03-02       Impact factor: 3.452

Review 10.  Diagnosis and management of postoperative pancreatic fistula.

Authors:  Giuseppe Malleo; Alessandra Pulvirenti; Giovanni Marchegiani; Giovanni Butturini; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2014-08-31       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.